Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “LAM”

571 trials

Showing 20 of 571 results

Not applicableStudy completedNCT04019873
What this trial is testing

'COMBINE-2': Real-world Evidence for Effectiveness of Two Drug Regimen, Antiretroviral Therapy With Integrase Inhibitors Plus a Reverse Transcriptase Inhibitor

Who this might be right for
HIV Infections
ViiV Healthcare 774
Large-scale testing (Phase 3)Study completedNCT00410202
What this trial is testing

Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus

Who this might be right for
Hepatitis B, Chronic
Bristol-Myers Squibb 629
Post-approval studies (Phase 4)Ended earlyNCT01014481
What this trial is testing

Appropriate Timing of HAART in Co-infected HIV/TB Patients

Who this might be right for
HIV InfectionsTuberculosis
Bamrasnaradura Infectious Diseases Institute 156
Large-scale testing (Phase 3)Study completedNCT00002245
What this trial is testing

The Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected Patients

Who this might be right for
HIV Infections
Glaxo Wellcome
Not applicableStudy completedNCT01770730
What this trial is testing

A Trial of the Urine LAM Strip Test for TB Diagnosis Amongst Hospitalized HIV-infected Patients

Who this might be right for
Tuberculosis
University of Cape Town 2,618
Large-scale testing (Phase 3)Study completedNCT02605954
What this trial is testing

Safety and Efficacy of Switching From Regimens of ABC/3TC + a 3rd Agent to E/C/F/TAF Fixed-Dose Combination (FDC) in Virologically-Suppressed HIV 1 Infected Adults

Who this might be right for
HIV-1 Infection
Gilead Sciences 275
Not applicableActive Not RecruitingNCT03042754
What this trial is testing

Improve Treatment Outcomes for Tuberculosis Infection in Tertiary Care Hospitals

Who this might be right for
Tuberculosis
The HIV Netherlands Australia Thailand Research Collaboration 150
Testing effectiveness (Phase 2)Study completedNCT00958100
What this trial is testing

Raltegravir Switch for Toxicity or Adverse Events

Who this might be right for
HIV/AIDSAntiretroviral TherapyHIV Infections
Catholic University of the Sacred Heart 40
Not applicableStudy completedNCT00014937
What this trial is testing

Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 240
Post-approval studies (Phase 4)UnknownNCT02482272
What this trial is testing

Compare Continuing Lamivudine Plus Adefovir or Adefovir Versus Switching to Entecavir Plus Adefovir in Patients With LAM-resistant Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Asan Medical Center 90
Not applicableWithdrawnNCT00001080
What this trial is testing

Effect of Vaccination on Turnover of Lamivudine (3TC) Sensitive and Resistant Virus Populations in HIV-1-Infected Individuals

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Large-scale testing (Phase 3)Study completedNCT02473146
What this trial is testing

Gemtuzumab Ozogamicin+Cytarabine vs Idarubicin+Cytarabine in Elderly Patients With AML.Mylofrance 4

Who this might be right for
Acute Myeloid Leukemia
Versailles Hospital 225
Testing effectiveness (Phase 2)Looking for participantsNCT04375800
What this trial is testing

Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)

Who this might be right for
Human Immunodeficiency Virus (HIV) Infection
Merck Sharp & Dohme LLC 84
Testing effectiveness (Phase 2)Ended earlyNCT04493216
What this trial is testing

A Dose-Range Finding Clinical Trial Study in Human Immunodeficiency Virus (HIV-1) Infected Treatment-Naive Adults

Who this might be right for
HIV Infections
ViiV Healthcare 161
Early research (Phase 1)UnknownNCT04273334
What this trial is testing

Application of 68Ga NEB PET Imaging in the Diagnosis and Evaluation of Lymphatic Disorders

Who this might be right for
Lymphatic Disorders
Peking Union Medical College Hospital 90
Large-scale testing (Phase 3)Study completedNCT00043888
What this trial is testing

Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR

Who this might be right for
HIV Infections
GlaxoSmithKline 60
Large-scale testing (Phase 3)Study completedNCT01656122
What this trial is testing

Abacavir and Lamivudine PK in Children

Who this might be right for
HIV
The HIV Netherlands Australia Thailand Research Collaboration 30
Not applicableUnknownNCT05617105
What this trial is testing

Molecular Characterization of Perivascular Epithelioid Cell Tumors

Who this might be right for
Perivascular Epithelioid Cell Tumor, Malignant
University Hospital, Strasbourg, France 100
Large-scale testing (Phase 3)Study completedNCT00000903
What this trial is testing

Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 444
Large-scale testing (Phase 3)Study completedNCT03446573
What this trial is testing

Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)

Who this might be right for
HIV Infections
ViiV Healthcare 743
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation